Literature DB >> 8284886

Heterogeneity of prostate cancer in radical prostatectomy specimens.

M Aihara1, T M Wheeler, M Ohori, P T Scardino.   

Abstract

OBJECTIVE: To understand the morphologic and spatial relationships of the various grades of prostate cancer, we investigated whether poorly differentiated cancer usually arises within the center of a large, well-differentiated tumor or more often forms the periphery or leading edge of the tumor.
METHODS: In a series of one hundred and one completely sectioned whole-mount radical prostatectomy specimens removed from patients with clinical Stage T2 prostate cancer, we mapped the distribution of each of the five Gleason grades and assessed their frequency, proportion, and spatial distribution.
RESULTS: The average number of different grades present in our patients was 2.7 (range 1-5). Over 50 percent of the prostates contained at least three different grades of cancer. The number of different Gleason grades present increased significantly with increasing tumor volume (p < 0.0001). Only 10 percent of the index cancers (largest tumor present) were composed of a single grade and these cancers were small (0.02-1.7 cm3). Among cancers with multiple grades, the most common finding (53%) was a high-grade cancer present within the core of a larger, more well-differentiated tumor; however, the opposite pattern, low-grade cancer present within a larger poorly differentiated cancer, was also common (30%) and predominated in very large cancers (> 10 cm3).
CONCLUSION: Small prostate cancers are often composed of a single grade, usually Gleason grade 2 or 3. But most palpable cancers contain multiple grades which are arranged in heterogeneous and unpredictable geographic interrelationships.

Entities:  

Mesh:

Year:  1994        PMID: 8284886     DOI: 10.1016/s0090-4295(94)80264-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  38 in total

Review 1.  Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.

Authors:  Takeshi Sasaki; Omar E Franco; Simon W Hayward
Journal:  Differentiation       Date:  2017-07-20       Impact factor: 3.880

2.  Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.

Authors:  S G Jhavar; C Fisher; A Jackson; S A Reinsberg; N Dennis; A Falconer; D Dearnaley; S E Edwards; S M Edwards; M O Leach; C Cummings; T Christmas; A Thompson; C Woodhouse; S Sandhu; C S Cooper; R A Eeles
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

3.  An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement.

Authors:  Cynthia Ménard; Robert C Susil; Peter Choyke; Jonathan Coleman; Robert Grubb; Ahmed Gharib; Axel Krieger; Peter Guion; David Thomasson; Karen Ullman; Sandeep Gupta; Virginia Espina; Lance Liotta; Emanuel Petricoin; Gabor Fitchtinger; Louis L Whitcomb; Ergin Atalar; C Norman Coleman; Kevin Camphausen
Journal:  Mol Imaging       Date:  2005 Jan-Mar       Impact factor: 4.488

4.  Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.

Authors:  John F Donohue; Fernando J Bianco; Kentaro Kuroiwa; Andrew J Vickers; Thomas M Wheeler; Peter T Scardino; Victor A Reuter; James A Eastham
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

5.  Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancer.

Authors:  Jochen Walz; Myriam Marcy; Jeanne Thomassin Pianna; Serge Brunelle; Gwenaelle Gravis; Naji Salem; Franck Bladou
Journal:  World J Urol       Date:  2011-05-26       Impact factor: 4.226

6.  Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy.

Authors:  Akhil Muthigi; Arvin K George; Abhinav Sidana; Michael Kongnyuy; Richard Simon; Vanessa Moreno; Maria J Merino; Peter L Choyke; Baris Turkbey; Bradford J Wood; Peter A Pinto
Journal:  J Urol       Date:  2016-08-28       Impact factor: 7.450

7.  Re-evaluating the concept of "dominant/index tumor nodule" in multifocal prostate cancer.

Authors:  Cheng Cheng Huang; Fang-Ming Deng; Max X Kong; Qinhu Ren; Jonathan Melamed; Ming Zhou
Journal:  Virchows Arch       Date:  2014-03-12       Impact factor: 4.064

Review 8.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

9.  Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.

Authors:  Lei Wei; Jianmin Wang; Erika Lampert; Simon Schlanger; Adam D DePriest; Qiang Hu; Eduardo Cortes Gomez; Mitsuko Murakam; Sean T Glenn; Jeffrey Conroy; Carl Morrison; Gissou Azabdaftari; James L Mohler; Song Liu; Hannelore V Heemers
Journal:  Eur Urol       Date:  2016-07-21       Impact factor: 20.096

10.  Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.

Authors:  Wennuan Liu; Sari Laitinen; Sofia Khan; Mauno Vihinen; Jeanne Kowalski; Guoqiang Yu; Li Chen; Charles M Ewing; Mario A Eisenberger; Michael A Carducci; William G Nelson; Srinivasan Yegnasubramanian; Jun Luo; Yue Wang; Jianfeng Xu; William B Isaacs; Tapio Visakorpi; G Steven Bova
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.